Determination of Labetalol Hydrochloride by Kinetic Spectrophotometry Using Potassium Permanganate as Oxidant

Authors

  • Nafisur Rahman Aligarh Muslim University
  • Nishat Anwar Keetham Agra U.P
  • Mohammad Kashif Ministry of Youth Affairs and Sports
  • Md. Nasrul Hoda Medical College of Georgia
  • Habibur Rahman Aligarh Muslim University

DOI:

https://doi.org/10.29356/jmcs.v55i2.840

Keywords:

Labetalol hydrochloride, kinetic spectrophotometry, initial rate and fixed time method

Abstract

A simple and sensitive kinetic spectrophotometric method was developed for the determination of labetalol (LBT) hydrochloride. The method was based on the kinetic investigation of the oxidation of the drug with alkaline potassium permanganate at room temperature (25 ± 1°C). The increase in absorbance of coloured manganate ions was measured at 605 nm. All experimental variables affecting the development of the colour were investigated and optimized. The initial rate and fixed time (at 6 minute) methods were adopted for determining the drug concentration. The calibration graphs were linear in the concentration ranges of 2-14 μg mL-1 and 1-10 μg mL-1, using the initial rate and fixed time methods, respectively. The method was successfully applied to the determination of labetalol in laboratory made tablets and commercial tablets. The results were validated statistically and through recovery studies.

Downloads

Download data is not yet available.

Author Biographies

Nafisur Rahman, Aligarh Muslim University

Analytical Research Division, Department of Chemistry

Nishat Anwar, Keetham Agra U.P

Anand Engineering College

Mohammad Kashif, Ministry of Youth Affairs and Sports

National Dope Testing Laboratory

Md. Nasrul Hoda, Medical College of Georgia

Department of Neurology

Habibur Rahman, Aligarh Muslim University

Analytical Research Division, Department of Chemistry

References

The British Pharmacopoeia, HMSO, London, 2004, Vol. I.

The United Sates Pharmacopoeia XXVII. The USP convection Rockville,MD, USA, 2004, 1060-1062

Witek, A.; Hopkala, H.; Matysik, G. Chromatographia 1999, 50, 41-44

Witek, A.; Hopkala, H.; Prazyborowski, L. Chem. Anal. 1998, 43, 817-822

Dakers, J. M.; Boulton, D. W.; Fawcett, J. P. J. Chromatogr. Sect. B. 1997, 704, 215-220

Cenicerors C., Maguregui M. I., Jimenez R. M., Alonso R. M. J. Chromatogr. Sec. B 1998, 705, 97-103

Zhao, H.; Li, H.; Qui, Z. Sepu 1999, 17, 369-371

Magali, D.; Charlotte, D.; Francois, P.; Philippe, D.; Jean-Claude, A. Forensic Sci. Int. 2004, 141, 23-31

Umezawa, H.; Lee, X. P.; Arima, Y.; Hasegawa, C.; Izawa, H.; Kumazawa, T.; Sato, K. Biomed. Chromatogr. 2008, 22, 702-711

Wu, J.; Lord, H. L.; Pawliszyn, J.; Kataoka, H. J. Microcolumn Sep. 2000, 12, 255-266

Gergov, M.; Robson, J. N.; Duchoslov, E.; Ojanpera, I. J. Mass Spectrum. 2000, 35, 912-918

Mario, T.; Georg, O.; Wilhelm, S. Biomed. Chromatogr. 2001, 15, 393-402

Maurer, H. H.; Tenberken, O.; Kratzsch, C. J. Chromatogr. A, 2004, 1058, 169-181

Le Potiera, I.; Tamisier- Karolak, S. L.; Morin, Ph.; Megel, F.; Taverna, M. J. Chromatogr. A 1998, 829, 341-349.

Tamisier- Khalendi, S. L.; Stanger, M. A.; Bommart, A. Electrophoresis 1999, 20, 2656-2663.

Wang, F.; Khalendi, M. G. Eletrophoresis 1998, 19, 2095-2100.

Salonies, H.; Luukkanen, L.; Knutila, R.; J. Pharm. Biomed. Anal. 1989, 7, 1447-1451

Radi, A.; El-Sherif, Z.; Wassel, A. Chem. Papers, 2004, 58, 242-246.

Iorio, M. A.; Farina, A. M.; Doldo, A. J. Pharm. Biomed. Anal. 1987, 5, 1-10.

Mohamed, M. E. Pharmazie 1983, 38, 784-785.

Belal F., Al-Shaboury A., Al-Tamrah A. S. J. Pharm. Biomed. Anal. 2002, 30, 1191-1196.

El-Wasseef, D. R.; El-Ashry, S. M.; Abu-El-Enien, M. A.; Moustafa, M. A. A. J. Food Drug Anal. 2006, 14, 133-140.

Rahman, N.; Manirul, H. Sk. Int. J. Biomed. Sci. 2008, 4, 140-146.

Sane, R. T.; Chandrashekhar, T. G.; Nayak, V. G. Indian Drugs 1986, 23, 565-568.

Sastry, C. S. P.; Krishna, D. M. Microchim. Acta. 1996, 122, 87-93.

Sastry, C. S. P.; Rao, S. G.; Shrinivas, K. R. Indian Drugs 1998, 35, 594-596.

Belal, F.; Al-Shaboury, S.; Al-Tamra, A. S. IL Farmaco 2003, 58, 293-299.

Rahman, N.; Rahman, H.; Azmi, S. N. H. J. Chin. Chem. Soc. 2007, 54, 185-196.

Salomies, H.; Luukkanen, L.; Knuutila, R. J. Pharm. Biomed. Anal. 1989, 7, 1447-1451.

International Conference on Harmonisation, ICH Harmonised Tripartite Guideline-Text on Validation of Analytical Procedures, Fed Regist. 1995; 60:11260.

Miller, J. N.; Miller, J. C. Statistics and Chemometrics for Analytical Chemistry; 4th ed., Pearson Education: England, 2000; p118.

Morelli, B. J. Pharm. Biomed. Anal. 2003, 32, 257-267.

Hartmann, C.; Verbeke, J. S.; Penninckx, W.; Heyden, Y. V.; Vankeerberghen, P.; Massart, D. L. Anal. Chem. 1995, 67, 4491-4499.

Acceptable methods in Drugs Directorate Guidelines, Canada Health Protection Branch, Ministry of National Health and Welfare,Draft, Ottawa, Canada, 1992.

Downloads

Published

2019-04-22

Issue

Section

Regular Articles